“…7 Such hearing loss isolates elderly patients from society and contributes to depression 8 and a subjective decrease in well-being. 9,10 Hearing aids have improved dramatically in recent years, 11 with advances being made in their use in elderly patients. 12 For those with severe-to-profound SNHL (≥70 dB) in whom amplification trials fail, cochlear implantation is the technique of choice.…”
mentioning
confidence: 99%
“…Hearing aids have improved dramatically in recent years, 11 with advances being made in their use in elderly patients 12 . For those with severe‐to‐profound SNHL (≥70 dB) in whom amplification trials fail, cochlear implantation is the technique of choice.…”
Cochlear implants are indicated for elderly patients with severe-to-profound hearing loss (sensorineural hearing loss >/=70 dB). Their use has been limited, possibly by the misconception that elderly patients will perform poorly. To document the performance of older adults (> or =65 years old), we undertook a retrospective analysis of our postlingually deafened adult patients who underwent implantation with the CLARION Multi-Strategy Cochlear Implant and underwent formal audiologic analysis (sentence recognition [Central Institute for the Deaf, CID] and monosyllabic word recognition (consonant-noun-consonant, CNC)). Both younger (n = 20; mean age = 46.9 years) and older (n = 16; mean age = 71.5 years) adults showed statistically significant increases in CID and CNC scores after cochlear implantation. No statistically significant difference could be detected in operative time, anesthesia time, length of hospitalization, or CID or CNC scores between the two age groups. We conclude that age should not be a criterion for deciding who should receive cochlear implants.
“…7 Such hearing loss isolates elderly patients from society and contributes to depression 8 and a subjective decrease in well-being. 9,10 Hearing aids have improved dramatically in recent years, 11 with advances being made in their use in elderly patients. 12 For those with severe-to-profound SNHL (≥70 dB) in whom amplification trials fail, cochlear implantation is the technique of choice.…”
mentioning
confidence: 99%
“…Hearing aids have improved dramatically in recent years, 11 with advances being made in their use in elderly patients 12 . For those with severe‐to‐profound SNHL (≥70 dB) in whom amplification trials fail, cochlear implantation is the technique of choice.…”
Cochlear implants are indicated for elderly patients with severe-to-profound hearing loss (sensorineural hearing loss >/=70 dB). Their use has been limited, possibly by the misconception that elderly patients will perform poorly. To document the performance of older adults (> or =65 years old), we undertook a retrospective analysis of our postlingually deafened adult patients who underwent implantation with the CLARION Multi-Strategy Cochlear Implant and underwent formal audiologic analysis (sentence recognition [Central Institute for the Deaf, CID] and monosyllabic word recognition (consonant-noun-consonant, CNC)). Both younger (n = 20; mean age = 46.9 years) and older (n = 16; mean age = 71.5 years) adults showed statistically significant increases in CID and CNC scores after cochlear implantation. No statistically significant difference could be detected in operative time, anesthesia time, length of hospitalization, or CID or CNC scores between the two age groups. We conclude that age should not be a criterion for deciding who should receive cochlear implants.
“…They also can have multiple memories for different acoustic responses. These advances hold great promise for true digital signal processing and greater satisfaction for the hearing impaired in the not-too-distant future (Stach & Gulya, 1996).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.